SEARCH

SEARCH BY CITATION

References

  • 1
    Hunter PR, Nichols G. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev 2002; 15: 14554.
  • 2
    Chen X-M, Keithly JS, Paya CV, LaRusso NF. Cryptosporidiosis. N Engl J Med 2002; 346: 172331.
  • 3
    MacKenzie WR, Hoxie NJ, Proctor ME, et al. A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply. N Engl J Med 1994; 331: 1617.
  • 4
    Morpeth SC, Thielman NM. Diarrhea in patients with AIDS. Curr Treat Options Gastroenterol 2006; 9: 2337.
  • 5
    Theodos CM, Griffiths JK, D'Onfro J, Fairfield A, Tzipori, S. Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models. Antimicrob Agents Chemother 1998; 42: 195965.
  • 6
    Blagburn B, Drain K, Land T, et al. Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a Neonatal Mouse Model. Antimicrob Agents Chemother 1998; 42: 287782.
  • 7
    Gargala G, Delauney A, Li XD, Brasseur P, Favennec L, Ballet JJ. Efficacy of nitazoxanide, tizoxanide and tizoxanide glucuronide against Cryptosporidium parvum development in sporozoite infected HCT-8 enterocytic cells. J Antimicrob Chemother 2000; 46: 5760.
  • 8
    Li X, Brasseur P, Agnamey P, et al. Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model. Folia Parasitol 2003; 50: 1922.
  • 9
    Baishanbo A, Gargala G, Duclos C, et al. Efficacy of nitazoxanide and paromomycin on biliary tract cryptosporidiosis in an immunosuppressed gerbil model. J Antimicrob Chemother 2006; 57: 3535.
  • 10
    Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective, double-blind placebo-controlled study of nitazoxanide. J Infect Dis 2001; 184: 1036.
  • 11
    Rossignol JF, Kabil SM, El-Gohary Y, Younis AM. Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species. Clin Gastroenterol Hepatol 2006; 4: 3204.
  • 12
    Amadi B, Miwiya M, Musuku J, et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet 2002; 360: 137580.
  • 13
    Rossignol JF, Hidalgo H, Feregrino M, et al. A double-blind placebo controlled study of nitazoxanide in the treatment of cryptosporidial diarrhea in AIDS patients. Trans R Soc Trop Med Hyg 1998; 92: 6636.